Understanding electrostatic and steric requirements related to hypertensive action of AT1 antagonists using molecular modeling techniques

被引:2
作者
Silva, Danielle da C. [1 ]
Maltarollo, Vinicius G. [1 ]
de Lima, Emmanuela Ferreira [2 ]
Weber, Karen Cacilda [3 ]
Honorio, Kathia M. [1 ,2 ]
机构
[1] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Santo Andre, Brazil
[2] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil
[3] Univ Fed Paraiba, BR-58059900 Joao Pessoa, Paraiba, Brazil
基金
巴西圣保罗研究基金会;
关键词
Angiotensin II; CoMFA analyses; Drug design; Hypertension; Molecular docking; Molecular dynamics simulations; Molecular modeling; ANGIOTENSIN-II ANTAGONISTS; FLAVONOID COMPOUNDS FLAVONES; 3D QSAR; SEMIEMPIRICAL METHODS; RECEPTOR; BINDING; SERIES; LIGANDS; POTENT; COMFA;
D O I
10.1007/s00894-014-2231-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AT(1) receptor is an interesting biological target involved in several important diseases, such as blood hypertension and cardiovascular pathologies. In this study we investigated the main electrostatic and steric features of a series of AT(1) antagonists related to hypertensive activity using structure and ligand-based strategies (docking and CoMFA). The generated 3D model had good internal and external consistency and was used to predict the potency of an external test set. The predicted values of pIC(50) are in good agreement with the experimental results of biological activity, indicating that the 3D model can be used to predict the biological property of untested compounds. The electrostatic and steric CoMFA maps showed molecular recognition patterns, which were analyzed with structure-based molecular modeling studies (docking). The most and the least potent compounds docked into the AT(1) binding site were subjected to molecular dynamics simulations with the aim to verify the stability and the flexibility of the ligand-receptor interactions. These results provided valuable insights on the electronic/structural requirements to design novel AT(1) antagonists.
引用
收藏
页数:14
相关论文
共 48 条
[1]   Structure-activity relationships for the design of small-molecule inhibitors [J].
Andricopulo, AD ;
Montanari, CA .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (06) :585-593
[2]  
[Anonymous], 1996, Biomolecular Simulation: the GROMOS96 Manual and User Guide
[3]   Molecular determinants of angiotensin II type 1 receptor functional selectivity [J].
Aplin, Mark ;
Bonde, Marie Mi ;
Hansen, Jakob Lerche .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (01) :15-24
[4]   NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS DERIVED FROM 1H-PYRAZOLE-5-CARBOXYLATES AND 4-ARYL-1H-IMIDAZOLE-5-CARBOXYLATES [J].
ASHTON, WT ;
HUTCHINS, SM ;
GREENLEE, WJ ;
DOSS, GA ;
CHANG, RSL ;
LOTTI, VJ ;
FAUST, KA ;
CHEN, TB ;
ZINGARO, GJ ;
KIVLIGHN, SD ;
SIEGL, PKS .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (23) :3595-3605
[5]   Model of the whole rat AT1 receptor and the ligand-binding site [J].
Baleanu-Gogonea, C ;
Karnik, S .
JOURNAL OF MOLECULAR MODELING, 2006, 12 (03) :325-337
[6]  
Berendsen HJ, 1981, Interaction models for water in relation to protein hydration, DOI DOI 10.1007/978-94-015-7658-1_21
[7]   GROMACS - A MESSAGE-PASSING PARALLEL MOLECULAR-DYNAMICS IMPLEMENTATION [J].
BERENDSEN, HJC ;
VANDERSPOEL, D ;
VANDRUNEN, R .
COMPUTER PHYSICS COMMUNICATIONS, 1995, 91 (1-3) :43-56
[8]   Binding sites of valsartan, candesartan and losartan with angiotensin II receptor 1 subtype by molecular modeling [J].
Bhuiyan, Mohiuddin Ahmed ;
Ishiguro, Masaji ;
Hossain, Murad ;
Nakamura, Takashi ;
Ozaki, Masanobu ;
Miura, Shin-ichiro ;
Nagatomo, Takafumi .
LIFE SCIENCES, 2009, 85 (3-4) :136-140
[9]   CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: Exploration of a binding mode at the active site [J].
Buolamwini, JK ;
Assefa, H .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :841-852
[10]   TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .2. DISCOVERY OF A POTENT AND ORALLY-ACTIVE TRIAZOLINONE ACYLSULFONAMIDE [J].
CHANG, LL ;
ASHTON, WT ;
FLANAGAN, KL ;
NAYLOR, EM ;
CHAKRAVARTY, PK ;
PATCHETT, AA ;
GREENLEE, WJ ;
BENDESKY, RJ ;
CHEN, TB ;
FAUST, KA ;
KLING, PJ ;
SCHAFFER, LW ;
SCHORN, TW ;
ZINGARO, GJ ;
CHANG, RSL ;
LOTTI, VJ ;
KIVLIGHN, SD ;
SIEGL, PKS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (01) :115-120